Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Jayant S Sanghvi has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE21-12-2015
21-12-2015
Sun Pharma gets USFDA warning letter on Halol facility
The US Food and Drug Administration had started inspections at the Halol plant in September 201419-12-2015
Sun Pharma receives Warning Letter for Halol facility
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated December 19, 2015, titled "Sun Pharma receives Warning Letter for Halol facility".19-12-2015
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Jayant S Sanghvi has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE15-12-2015
Sun Pharma sells Ohio facility to Nostrum Laboratories
The move is part of Sun Pharmas manufacturing consolidation in the US14-12-2015
Sun Pharma announces divestment of US manufacturing unit
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated December 14, 2015 titled "Sun Pharma announces divestment of US manufacturing unit".14-12-2015
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
Tejaskiran Pharmachem Industries Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE10-12-2015
Sun Pharma signs pact to develop brain stroke drug
Sun Pharma will have the exclusive option to further develop the enzyme after completion of the preclinical studies10-12-2015
Sun Pharma announces research collaboration with Weizmann Institute of Science, Israel & Health Research Institute of Santiago, Spain for brain therapies
Sun Pharmaceutical Industries Ltd has informed BSE regarding a Press Release dated December 10, 2015 titled "Sun Pharma announces research collaboration with Weizmann Institute of Science, Israel & Health Research Institute of Santiago, Spain for brain therapies".10-12-2015
Sun Pharma up 2% as Street cheers USFDA approval
Brokering houses remained positive on the stock, with CLSA and Bank of America-Meryll Lynch (BofA ML) maintaining buy ratings on the scrip.07-12-2015